This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Pruritus ( itching ) in hyperthyroidism ( thyrotoxicosis )

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • pruritus and alopecia may be a presenting features of hyperthyroidism
  • a retrospective study of 236 thyrotoxic patients seen in the thyroid clinic was undertaken
    • 18.65% of these patterns had one or more dermatological complaints at presentation
    • there was no specific difference in this group of patients when compared with the general hyperthyroid population with regard to age, race, sex, duration of hyperthyroidism or biochemical indices of thyrotoxicosis
    • the two major complaints were itching and alopecia
      • the prevalence of pruritus was 6.4%
      • the prevalence of alopecia was 2.6%
      • these symptoms cleared quickly when these patients became euthyroid. However there were other patients who noted hair loss with anti-thyroid medications

Reference:

  1. The prevalence of skin manifestations in thyrotoxicosis--a retrospective study. Med J Malaysia. 1989 Dec;44(4):324-8.

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.